Effect of Early vs Late Intervention With Inhaled Corticosteroids in Asthma

作者: Olof Selroos , Anne Pietinalho , Ann-Britt Löfroos , Henrik Riska

DOI: 10.1378/CHEST.108.5.1228

关键词:

摘要: One hundred five consecutive patients with mild or moderate asthma not earlier treated inhaled corticosteroids and a need of an bronchodilator three more doses week, and/or symptoms during day night, peak expiratory flow (PEF) FEV 1 less than 75% predicted normal values were given corticosteroid for 2 years (budesonide delivered via inspiratory flow-driven multidose dry powder inhaler [Turbuhaler]). According to duration symptoms, they divided into six groups; from 6 months up 10 years. PEF measured before after treatment 3 months, year, In the groups years, mean significantly higher at all time points as compared baseline longer symptoms. The maximum effects usually seen year's maintained control second year. A significant negative correlation was found between increases in (r=-0.34;p=0.0006) (r=-0.32;p=0.0012), remaining also correcting airway function. No age regular use s -agonists improvements results give some evidence that early steroid may prevent developing chronic obstruction. They support current guidelines advocating introduction anti-inflammatory drugs.

参考文章(14)
Ann Woolcock, J. Paul Seale, Abraham R. Rubinfeld, Louis L. Landau, Ral Antic, Charles Mitchell, Harold H. Rea, Paul Zimmerman, Asthma management plan, 1989 The Medical Journal of Australia. ,vol. 151, pp. 650- 653 ,(1989) , 10.5694/J.1326-5377.1989.TB139640.X
FE Hargreave, J Dolovich, MT. Newhouse, None, The assessment and treatment of asthma: a conference report. The Journal of Allergy and Clinical Immunology. ,vol. 85, pp. 1098- 1111 ,(1990) , 10.1016/0091-6749(90)90056-A
Kr Chapman, S. Kesten, J.P. Szalai, Regular vs as-needed inhaled salbutamol in asthma control The Lancet. ,vol. 343, pp. 1379- 1382 ,(1994) , 10.1016/S0140-6736(94)92520-8
L. Thorsson, S. Edsbäcker, T-B. Conradson, Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI European Respiratory Journal. ,vol. 7, pp. 1839- 1844 ,(1994) , 10.1183/09031936.94.07101839
D. Robin Taylor, Malcolm R. Sears, Regular Beta-Adrenergic Agonists Chest. ,vol. 106, pp. 552- 559 ,(1994) , 10.1378/CHEST.106.2.552
A. A. Viljanen, P. K. Halttunen, K.-E. Kreus, B. C. Viljanen, Spirometric Studies in Non-Smoking, Healthy Adults Scandinavian Journal of Clinical & Laboratory Investigation. ,vol. 159, pp. 5- 20 ,(1982) , 10.1080/00365518209168377
Lauri A. Laitinen, Annika Laitinen, Matti Heino, Tari Haahtela, Eosinophilic Airway Inflammation during Exacerbation of Asthma and Its Treatment with Inhaled Corticosteroid American Review of Respiratory Disease. ,vol. 143, pp. 423- 427 ,(1991) , 10.1164/AJRCCM/143.2.423